NovoCure Ltd. (NVCR)

10.14 +0.05 (+0.50%) USD  |  NASDAQ  |  Feb 06, 16:00
10.14 0.00 (0.00%) After-Hours: 20:00
More

NovoCure SG&A Expense (TTM) : 445.94M for Sept. 30, 2025

SG&A Expense (TTM) Chart

View SG&A Expense (TTM) for NVCR.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View SG&A Expense (TTM) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

SG&A Expense (TTM) Range, Past 5 Years

View SG&A Expense (TTM) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

SG&A Expense (TTM) Benchmarks

View SG&A Expense (TTM) Benchmarks
Start Trial
LivaNova Plc 545.57M
Abbott Laboratories 12.33B
Accuray, Inc. 88.55M
Alphatec Holdings, Inc. 484.37M
Plus Therapeutics, Inc. 11.09M